A Comparative Chemogenomics Strategy to Predict Potential Drug Targets in the Metazoan Pathogen, Schistosoma mansoni
Conor R. Caffrey, Andreas Rohwer, Frank Oellien et al. · 2009
Read A Comparative Chemogenomics Strategy to Predict Potential Drug Targets in the Metazoan Pathogen, Schistosoma mansoni by Conor R. Caffrey, Andreas Rohwer, Frank Oellien et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0004413.txt.
Description
A parasitic worm disease still relies on a single drug. Conor Caffrey, Andreas Rohwer, Frank Oellien, and co-authors hunt for new targets in this 2009 PLOS ONE article. Schistosomiasis is a prevalent, chronic helminth disease in tropical regions, treated mainly with praziquantel.
Reliance on one drug is risky if clinically relevant resistance emerges and spreads. The authors use a comparative chemogenomics strategy to predict potential drug targets in Schistosoma mansoni. Comparing drug data across species can reveal the worm's weak points. New targets could back up the sole drug. Chemogenomics borrows drug data from other species to rank the worm's targets fast.
Catalog record
| CREATOR | Conor R. Caffrey, Andreas Rohwer, Frank Oellien et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0004413